Eurofins Amatsigroup

Foundation date

19/10/2007

Sector

#Biotechnology / R&D Services

Subsector

Eurofins CDMO is a leading international & innovative CDMO and a one-stop-shop partner guiding you from (pre-)clinical development to clinical manufacturing & logistics.
Our expertise lies in drug substance development & manufacturing for biologics and drug product development & manufacturing for small molecules and biologics.
We specifically have a long-term record in handling complex proteins, producing live/inactivated vaccines, enhancing strategies for compounds with low solubility (highway to clinic) and colon-targeted formulations.
We can offer a broad range of dosage forms and manufacturing can be performed in a non-sterile or sterile way, always supported by a large portfolio of analytical methods.
Eurofins CDMO is a trusted partner, where innovation is key to help customers with their life-saving medicines.

Latest news

  • Waste2Func Video Release: The technology is ready, are we?

    Friday May 24th 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapumpĀ®

    Wednesday May 22nd 2024

Jobs by Eurofins Amatsigroup